SCHEMBL7260835

SCHEMBL7260835

CC(C)(C)OC(=O)NC(Cc1ccc(Nc2nc(-c3ccccc3)cc3ccncc23)cc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.48
PTPN1 P18031 3/20 0.45
ITGB3 P05106 2/20 0.44
ITGA2B P08514 2/20 0.44
ITGB1 P05556 1/20 0.44
ITGAV P06756 1/20 0.44
ITGB5 P18084 1/20 0.44
PTPRB P23467 3/20 0.44
CTSS P25774 4/20 0.44
CTSK P43235 3/20 0.44
ITGA4 P13612 2/20 0.44
ITGB7 P26010 2/20 0.44
CTSB P07858 2/20 0.41
CTSL P07711 1/20 0.41
PPARA Q07869 2/20 0.41
PPARG P37231 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7260830 1.00 ACE (0.48) ACEPTPN1ITGB3ITGA2BITGB1
Hydrochloric Acid SCHEMBL5262115 0.88 ACE (0.46) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL7264852 0.85 PTPN1 (0.49) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL7264856 0.85 PTPN1 (0.49) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL2978498 0.81 ITGB3 (0.48) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL7104303 0.81 ITGB3 (0.48) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL7259564 0.80 KLK5 (0.44) ACEITGB3ITGA2BITGB1ITGAV
SCHEMBL7105100 0.79 ACE (0.52) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL7105095 0.79 ACE (0.52) ACEPTPN1ITGB3ITGA2BITGB1
SCHEMBL7716450 0.79 ACE (0.52) ACEPTPN1ITGB3ITGA2BITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6593338-B2 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells. CELLTECH R&D LIMITED (GB) 2003-07-15 US disclosed